Using a Program to Lower Stress for Caregivers of Patients With Cancer Who Have Received Stem Cell Transplants

Authors:
  • TSTeresa Simoneau
    Teresa Simoneau
  • SMSusan Mikulich-Gilbertson
    Susan Mikulich-Gilbertson
  • BBBenjamin Brewer
    Benjamin Brewer
  • KKKristin Kilbourn
    Kristin Kilbourn
  • JGJon Gutman
    Jon Gutman
  • PMPeter McSweeney
    Peter McSweeney

Abstract
Hematopoietic stem cell transplants (HSCT) are a treatment option for diseases of the blood such as leukemia. The patient is conditioned by removing (ablating) their blood cells, either in whole or in part by radiation and/or chemotherapy. Their cancerous blood cells are replaced (transplanted) with either some of their own blood cells that were “cleaned” and preserved (autologous HSCT) or those from a closely matched donor (allogeneic HSCT).